本页面由Tiger Trade Technology Pte. Ltd.提供服务

Purple Biotech Ltd.

0.5760
-0.0090-1.54%
成交量:10.27万
成交额:5.98万
市值:520.15万
市盈率:-0.53
高:0.5945
开:0.5751
低:0.5702
收:0.5850
52周最高:3.48
52周最低:0.5326
股本:903.04万
流通股本:835.82万
量比:1.39
换手率:1.23%
股息:- -
股息率:- -
每股收益(TTM):-1.0840
每股收益(LYR):-4.4158
净资产收益率:-10.48%
总资产收益率:-8.48%
市净率:0.16
市盈率(LYR):-0.13

数据加载中...

2025/08/30

SEC问询函

Form CORRESP - Correspondence
2025/08/30

SEC问询函

Form CORRESP - Correspondence
2025/08/29

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2025/03/10

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/11/15

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/07/27

SEC问询函

Form CORRESP - Correspondence
2024/07/22

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2024/03/05

年度报告

Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2023/11/14

SEC问询函

Form CORRESP - Correspondence
2023/11/14

[修订]招股说明书

Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
2023/10/31

招股说明书

Form F-1 - Registration statement for certain foreign private issuers
2023/05/18

SEC问询函

Form CORRESP - Correspondence
2023/04/03

SEC问询函

CORRESP [Cover] - Correspondence
2023/03/03

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2022/04/04

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/09

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/04/09

超过5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/03/16

[修订]年度报告

20-F/A [Amend] - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]
2021/03/16

年度报告

20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)]